Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-24-004277
Filing Date
2024-06-17
Accepted
2024-06-17 16:21:10
Documents
5
Effectiveness Date
2024-06-17

Document Format Files

Seq Description Document Type Size
1 S-8 sonoma_s8.htm S-8 49423
2 OPINION OF POLSINELLI PC sonoma_ex0501.htm EX-5.1 8503
3 CONSENT OF FRAZIER & DEETER, LLC sonoma_ex2301.htm EX-23.1 1992
4 CALCULATION OF FILING FEE TABLE sonoma_ex107.htm EX-FILING FEES 15899
5 GRAPHIC image_059.jpg GRAPHIC 2736
  Complete submission text file 0001683168-24-004277.txt   80874
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-280268 | Film No.: 241048565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)